West Pharmaceutical Services EBITDA 2010-2025 | WST
West Pharmaceutical Services EBITDA for the quarter ending March 31, 2025 was $0.200B, a 1.78% increase year-over-year.
- West Pharmaceutical Services 2024 EBITDA was 0.725B, a 10.82% decline from 2023.
- West Pharmaceutical Services 2023 EBITDA was 0.813B, a 4.83% decline from 2022.
- West Pharmaceutical Services 2022 EBITDA was 0.855B, a 2.29% decline from 2021.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.